Published in Lasers Surg Med on February 01, 2005
Recent progress in tissue optical clearing. Laser Photon Rev (2013) 1.46
Following dimethyl sulfoxide skin optical clearing dynamics with quantitative nonlinear multimodal microscopy. Appl Opt (2009) 1.10
Enhancement of optical skin clearing efficacy using a microneedle roller. J Biomed Opt (2008) 1.04
Mechanical tissue optical clearing devices: enhancement of light penetration in ex vivo porcine skin and adipose tissue. Lasers Surg Med (2008) 1.00
Optical histology: a method to visualize microvasculature in thick tissue sections of mouse brain. PLoS One (2013) 0.98
Revisiting optical clearing with dimethyl sulfoxide (DMSO). Lasers Surg Med (2009) 0.96
Microtome-free 3-dimensional confocal imaging method for visualization of mouse intestine with subcellular-level resolution. Gastroenterology (2009) 0.94
Application of an optical clearing agent during noninvasive laser coagulation of the canine vas deferens. J Biomed Opt (2010) 0.91
Ultraviolet C inactivation of dermatophytes: implications for treatment of onychomycosis. Br J Dermatol (2008) 0.83
Optical properties of mouse brain tissue after optical clearing with FocusClear™. J Biomed Opt (2015) 0.79
Optical clearing of the skin for near-infrared fluorescence image-guided surgery. J Biomed Opt (2009) 0.78
Clearing and Labeling Techniques for Large-Scale Biological Tissues. Mol Cells (2016) 0.76
Optical clearing of vaginal tissues, ex vivo, for minimally invasive laser treatment of female stress urinary incontinence. J Biomed Opt (2017) 0.75
Feasibility of a hybrid elastographic-microfluidic device to rapidly process and assess pancreatic cancer biopsies for pathologists. Health Innov Point Care Conf (2014) 0.75
PARAMETRIC STUDY OF TISSUE OPTICAL CLEARING BY LOCALIZED MECHANICAL COMPRESSION USING COMBINED FINITE ELEMENT AND MONTE CARLO SIMULATION. J Innov Opt Health Sci (2010) 0.75
Multiple laser pulses in conjunction with an optical clearing agent to improve the curative effect of cutaneous vascular lesions. Lasers Med Sci (2017) 0.75
Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol (2013) 3.76
Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: a large retrospective study. Eur J Cancer (2012) 2.54
Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial. J Clin Oncol (2005) 2.52
Remote plethysmographic imaging using ambient light. Opt Express (2008) 2.37
Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domains. Hum Gene Ther (2007) 2.23
Laser speckle imaging for monitoring blood flow dynamics in the in vivo rodent dorsal skin fold model. Microvasc Res (2004) 2.03
Real-time phase-resolved functional optical coherence tomography by use of optical Hilbert transformation. Opt Lett (2002) 2.00
Removal of a mirror image and enhancement of the signal-to-noise ratio in Fourier-domain optical coherence tomography using an electro-optic phase modulator. Opt Lett (2005) 1.98
Reversible dissociation of collagen in tissues. J Invest Dermatol (2003) 1.64
Description and analysis of treatments for port-wine stain birthmarks. Arch Facial Plast Surg (2005) 1.62
SAVE (Super-dose anti-VEGF) trial: 2.0 mg ranibizumab for recalcitrant neovascular age-related macular degeneration: 1-year results. Ophthalmic Surg Lasers Imaging Retina (2013) 1.60
High-resolution optical coherence tomography over a large depth range with an axicon lens. Opt Lett (2002) 1.50
Noninvasive blood flow imaging for real-time feedback during laser therapy of port wine stain birthmarks. Lasers Surg Med (2008) 1.47
Combining Smoothened Agonist (SAG) and NEL-like protein-1 (NELL-1) Enhances Bone Healing. Plast Reconstr Surg (2017) 1.40
Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer. Oral Oncol (2012) 1.38
Microvascular blood flow dynamics associated with photodynamic therapy, pulsed dye laser irradiation and combined regimens. Lasers Surg Med (2006) 1.35
Imaging and quantifying transverse flow velocity with the Doppler bandwidth in a phase-resolved functional optical coherence tomography. Opt Lett (2002) 1.33
Optical clearing of in vivo human skin: implications for light-based diagnostic imaging and therapeutics. Lasers Surg Med (2004) 1.32
Spectral shaping for non-Gaussian source spectra in optical coherence tomography. Opt Lett (2002) 1.29
Imaging wound healing using optical coherence tomography and multiphoton microscopy in an in vitro skin-equivalent tissue model. J Biomed Opt (2004) 1.23
Long-term blood vessel removal with combined laser and topical rapamycin antiangiogenic therapy: implications for effective port wine stain treatment. Lasers Surg Med (2010) 1.21
Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors. J Hematol Oncol (2014) 1.20
Host factors that affect Ty3 retrotransposition in Saccharomyces cerevisiae. Genetics (2004) 1.19
Blood flow dynamics after laser therapy of port wine stain birthmarks. Lasers Surg Med (2009) 1.16
Determination of burn depth by polarization-sensitive optical coherence tomography. J Biomed Opt (2004) 1.14
Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation. Radiother Oncol (2012) 1.12
Clinical testing of a photoacoustic probe for port wine stain depth determination. Lasers Surg Med (2002) 1.12
Treatment of cutaneous vascular lesions using multiple-intermittent cryogen spurts and two-wavelength laser pulses: numerical and animal studies. Lasers Surg Med (2007) 1.11
Phase 2 trial of preoperative irinotecan plus cisplatin and conformal radiotherapy, followed by surgery for esophageal cancer. Cancer (2010) 1.08
Collagen solubility correlates with skin optical clearing. J Biomed Opt (2006) 1.07
Low-noise broadband light generation from optical fibers for use in high-resolution optical coherence tomography. J Opt Soc Am A Opt Image Sci Vis (2005) 1.07
Effects of combined inhibition of MEK and mTOR on downstream signaling and tumor growth in pancreatic cancer xenograft models. Cancer Biol Ther (2009) 1.06
Super-dose anti-VEGF (SAVE) trial: 2.0 mg intravitreal ranibizumab for recalcitrant neovascular macular degeneration-primary end point. Ophthalmology (2012) 1.05
Depth-resolved birefringence and differential optical axis orientation measurements with fiber-based polarization-sensitive optical coherence tomography. Opt Lett (2004) 1.05
Enhancement of optical skin clearing efficacy using a microneedle roller. J Biomed Opt (2008) 1.04
Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling. Int J Cancer (2006) 1.04
Polarization color imaging system for on-line quantitative evaluation of facial skin lesions. Dermatol Surg (2007) 1.03
A dataset of human liver proteins identified by protein profiling via isotope-coded affinity tag (ICAT) and tandem mass spectrometry. Mol Cell Proteomics (2004) 1.03
Foreign versus domestic education of physicians for the United States: a case study of physicians of South Asian ethnicity in California. J Health Care Poor Underserved (2007) 1.02
Analysis of facial sebum distribution using a digital fluorescent imaging system. J Biomed Opt (2007) 1.00
Effects of mass flow rate and droplet velocity on surface heat flux during cryogen spray cooling. Phys Med Biol (2003) 1.00
Mechanical tissue optical clearing devices: enhancement of light penetration in ex vivo porcine skin and adipose tissue. Lasers Surg Med (2008) 1.00
Characterization of port wine stain skin erythema and melanin content using cross-polarized diffuse reflectance imaging. Lasers Surg Med (2004) 1.00
A physical method to enhance transdermal delivery of a tissue optical clearing agent: combination of microneedling and sonophoresis. Lasers Surg Med (2010) 1.00
Spatial frequency domain imaging of port wine stain biochemical composition in response to laser therapy: a pilot study. Lasers Surg Med (2012) 0.99
In vivo port-wine stain depth determination with a photoacoustic probe. Appl Opt (2003) 0.98
Non-contact heart rate monitoring utilizing camera photoplethysmography in the neonatal intensive care unit - a pilot study. Early Hum Dev (2013) 0.98
Calcium phosphate-DNA nanoparticle gene delivery from alginate hydrogels induces in vivo osteogenesis. J Biomed Mater Res A (2010) 0.98
Confocal microscopy study of nerves and blood vessels in untreated and treated port wine stains: preliminary observations. Dermatol Surg (2004) 0.98
Use of erythema index imaging for systematic analysis of port wine stain skin response to laser therapy. Lasers Surg Med (2005) 0.97
Hemoglobin contrast in magnetomotive optical Doppler tomography. Opt Lett (2006) 0.97
Combined photodynamic and photothermal induced injury enhances damage to in vivo model blood vessels. Lasers Surg Med (2004) 0.97
Cascade of reduced speed and accuracy after errors in enzyme-free copying of nucleic acid sequences. J Am Chem Soc (2012) 0.97
Can topically applied optical clearing agents increase the epidermal damage threshold and enhance therapeutic efficacy? Lasers Surg Med (2004) 0.96
Rate process analysis of thermal damage in cartilage. Phys Med Biol (2003) 0.96
Remittance at a single wavelength of 390 nm to quantify epidermal melanin concentration. J Biomed Opt (2009) 0.96
Induction of apoptosis in IL-3-dependent hematopoietic cell lines by guanine nucleotide depletion. Blood (2003) 0.95
Improvement of port wine stain laser therapy by skin preheating prior to cryogen spray cooling: a numerical simulation. Lasers Surg Med (2006) 0.95
Determination of human skin optical properties from spectrophotometric measurements based on optimization by genetic algorithms. J Biomed Opt (2005) 0.95
Hypertrophic scarring of the neck following ablative fractional carbon dioxide laser resurfacing. Lasers Surg Med (2009) 0.94
Hypotony after 25-gauge vitrectomy using oblique versus direct cannula insertions in fluid-filled eyes. Retina (2008) 0.93
An overview of three promising mechanical, optical, and biochemical engineering approaches to improve selective photothermolysis of refractory port wine stains. Ann Biomed Eng (2011) 0.93
Treatment of hypertrophic and resistant port wine stains with a 755 nm laser: a case series of 20 patients. Lasers Surg Med (2009) 0.93
Topical rapamycin suppresses the angiogenesis pathways induced by pulsed dye laser: molecular mechanisms of inhibition of regeneration and revascularization of photocoagulated cutaneous blood vessels. Lasers Surg Med (2012) 0.93
A Phase I trial of prolonged administration of lovastatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or of the cervix. Eur J Cancer (2005) 0.93
A phase II trial of second-line axitinib following prior antiangiogenic therapy in advanced hepatocellular carcinoma. Cancer (2015) 0.92
A phase I/II study of the Src inhibitor saracatinib (AZD0530) in combination with gemcitabine in advanced pancreatic cancer. Invest New Drugs (2010) 0.92
Ancient eudicot hexaploidy meets ancestral eurosid gene order. BMC Genomics (2013) 0.92
Comparing the effectiveness of 585-nm vs 595-nm wavelength pulsed dye laser treatment of port wine stains in conjunction with cryogen spray cooling. Lasers Surg Med (2002) 0.91
Infrared measurement of human skin temperature to predict the individual maximum safe radiant exposure (IMSRE). Lasers Surg Med (2007) 0.91
How leaky is the health career pipeline? Minority student achievement in college gateway courses. Acad Med (2009) 0.91
Decreased dendritic spine density and abnormal spine morphology in Fyn knockout mice. Brain Res (2011) 0.91
Treatment of port-wine stain birthmarks using the 1.5-msec pulsed dye laser at high fluences in conjunction with cryogen spray cooling. Dermatol Surg (2002) 0.90
Determination of optimal view angles for quantitative facial image analysis. J Biomed Opt (2005) 0.90
In vivo, high-resolution, three-dimensional imaging of port wine stain microvasculature in human skin. Lasers Surg Med (2013) 0.90
Cryogen spray cooling efficiency: improvement of port wine stain laser therapy through multiple-intermittent cryogen spurts and laser pulses. Lasers Surg Med (2002) 0.89
Host factor transcriptional regulation contributes to preferential expression of HIV type 1 in IL-4-producing CD4 T cells. J Immunol (2012) 0.88
Accurate measurement of blood vessel depth in port wine stained human skin in vivo using pulsed photothermal radiometry. J Biomed Opt (2004) 0.88
Stem cell marker upregulation in normal cutaneous vessels following pulsed-dye laser exposure and its abrogation by concurrent rapamycin administration: implications for treatment of port-wine stain birthmarks. J Cutan Pathol (2010) 0.88
A multicenter, randomized, open-label study to assess the steady-state pharmacokinetics of bevacizumab given with either XELOX or FOLFOX-4 in patients with metastatic colorectal cancer. Cancer Chemother Pharmacol (2011) 0.88
Influence of wavelength on response to laser photothermolysis of blood vessels: implications for port wine stain laser therapy. Lasers Surg Med (2003) 0.87
Comparison of diffusion approximation and Monte Carlo based finite element models for simulating thermal responses to laser irradiation in discrete vessels. Phys Med Biol (2005) 0.87
Pilot study examining the combined use of pulsed dye laser and topical Imiquimod versus laser alone for treatment of port wine stain birthmarks. Lasers Surg Med (2008) 0.87
Spectral variation of the infrared absorption coefficient in pulsed photothermal profiling of biological samples. Phys Med Biol (2002) 0.87
Computational model to evaluate port wine stain depth profiling using pulsed photothermal radiometry. J Biomed Opt (2004) 0.87
Cutaneous effects of cryogen spray cooling on in vivo human skin. Dermatol Surg (2006) 0.87
Correlation between collagen solubility and skin optical clearing using sugars. Lasers Surg Med (2007) 0.87
Compensation of polarization-dependent loss in transmission fiber gratings by use of a Sagnac loop interferometer. Opt Lett (2005) 0.86
Change in spinal alignment after total hip arthroplasty. Orthop Surg (2013) 0.85
Numerical optimization of sequential cryogen spray cooling and laser irradiation for improved therapy of port wine stain. Lasers Surg Med (2011) 0.85
Influence of laser wavelength and pulse duration on gas bubble formation in blood filled glass capillaries. Lasers Surg Med (2005) 0.85
Imaging nanoparticle flow using magneto-motive optical Doppler tomography. Nanotechnology (2007) 0.84